National Bank of Canada’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-41
| Closed | -$93 | – | 2660 |
|
|
2024
Q1 | $93 | Sell |
41
-2
| -5% | -$5 | ﹤0.01% | 2478 |
|
|
2023
Q4 | $301 | Hold |
43
| – | – | ﹤0.01% | 2440 |
|
|
2023
Q3 | $383 | Hold |
43
| – | – | ﹤0.01% | 2438 |
|
|
2023
Q2 | $909 | Hold |
43
| – | – | ﹤0.01% | 2391 |
|
|
2023
Q1 | $1.15K | Hold |
43
| – | – | ﹤0.01% | 2370 |
|
|
2022
Q4 | $1.5K | Hold |
43
| – | – | ﹤0.01% | 2364 |
|
|
2022
Q3 | $10K | Buy |
43
+35
| +438% | +$8.14K | ﹤0.01% | 2017 |
|
|
2022
Q2 | $2K | Hold |
8
| – | – | ﹤0.01% | 2437 |
|
|
2022
Q1 | $2K | Hold |
8
| – | – | ﹤0.01% | 2495 |
|
|
2021
Q4 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 2544 |
|